AMPK activation reduces vascular permeability and airway inflammation by regulating HIF/VEGFA pathway in a murine model of toluene diisocyanate-induced asthma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AMPK activation reduces vascular permeability and airway inflammation by regulating HIF/VEGFA pathway in a murine model of toluene diisocyanate-induced asthma
Authors
Keywords
-
Journal
INFLAMMATION RESEARCH
Volume 61, Issue 10, Pages 1069-1083
Publisher
Springer Nature
Online
2012-06-15
DOI
10.1007/s00011-012-0499-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adenosine 5'-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype
- (2014) D. Sag et al. JOURNAL OF IMMUNOLOGY
- A Novel Dithiol Amide CB3 Attenuates Allergic Airway Disease through Negative Regulation of p38 Mitogen-activated Protein Kinase
- (2011) So Ri Kim et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Peripheral Th1/Th2/Th17/regulatory T-cell balance in asthmatic pregnancy
- (2011) G. Toldi et al. INTERNATIONAL IMMUNOLOGY
- Th1/Th2/Th17 and Regulatory T-Cell Paradigm in Pregnancy
- (2010) Shigeru Saito et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Role of Treg in immune regulation of allergic diseases
- (2010) Oscar Palomares et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- HIF-1 and HIF-2 transcription factors — Similar but not identical
- (2010) Agnieszka Loboda et al. MOLECULES AND CELLS
- AMP-activated protein kinase: a core signalling pathway in the heart
- (2009) A. S. Kim et al. Acta Physiologica
- Angiogenesis in asthma
- (2009) D. Ribatti et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Regulatory T cells and asthma
- (2009) D. S. Robinson CLINICAL AND EXPERIMENTAL ALLERGY
- Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells
- (2009) A. Peairs et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease
- (2009) Aaron K. F. Wong et al. CLINICAL SCIENCE
- A potential role for reactive oxygen species and the HIF-1α–VEGF pathway in hypoxia-induced pulmonary vascular leak
- (2009) David C. Irwin et al. FREE RADICAL BIOLOGY AND MEDICINE
- Regulatory T Cells in Asthma
- (2009) Clare M. Lloyd et al. IMMUNITY
- Innate Cells and T Helper 2 Cell Immunity in Airway Inflammation
- (2009) Nora A. Barrett et al. IMMUNITY
- Th17 Immunity in Patients with Allergic Asthma
- (2009) Yang Zhao et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Mechanisms of occupational asthma
- (2009) Piero Maestrelli et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Tissue Transglutaminase Can Be Involved in Airway Inflammation of Toluene Diisocyanate-Induced Occupational Asthma
- (2009) Gyu-Young Hur et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Metformin Attenuated the Autoimmune Disease of the Central Nervous System in Animal Models of Multiple Sclerosis
- (2009) N. Nath et al. JOURNAL OF IMMUNOLOGY
- Understanding Asthma Using Animal Models
- (2009) Yoo Seob Shin et al. Allergy Asthma & Immunology Research
- Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury
- (2008) Xia Zhao et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Strategies for use of IL-10 or its antagonists in human disease
- (2008) Anne O'Garra et al. IMMUNOLOGICAL REVIEWS
- AMP-Activated Protein Kinase Activation by 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) Inhibits Palmitate-Induced Endothelial Cell Apoptosis Through Reactive Oxygen Species Suppression
- (2008) Ji-Eun Kim et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started